SELENOP and Alzheimer disease: In addition, our findings suggest that when assessing the relation between selenoprotein P concentrations and incidence of non-Alzheimer’s dementia, it is necessary to rely on CSF concentrations of the biomarker rather than its blood levels, differently from what appears to be true for Alzheimer’s dementia.